Navigation Links
The nanomechanical signature of breast cancer
Date:2/1/2013

Philadelphia, Pa. The texture of breast cancer tissue differs from that of healthy tissue. Using a cutting-edge tissue diagnostic device, a group of researchers in Basel, Switzerland, has determined one key difference: cancerous tissue is a mix of stiff and soft zones, whereas healthy tissue has uniform stiffness. This new finding may one day help improve breast cancer diagnosis and therapy by providing a unique nanomechanical signature of tumor tissue properties that indicates the potential for the cancer to spread. The team will present its work at the 57th Annual Meeting of the Biophysical Society (BPS), held Feb. 2-6, 2013, in Philadelphia, Pa.

"It is slowly being recognized that a key to the cancer problem lies in the physical properties of the tumor tissue and that biomechanics plays a key role in cancer cell migration, invasion, and metastasis," explains Marija Plodinec of the University of Basel in Switzerland. However, contradictory opinions persist about tissue texture, and the information is hard to get at cellular mechanics happen at the nanoscale, 1-100 millionths of a meter. This research may help resolve the controversy.

To determine stiffness, the team applied a nanoscale microscope tip to a breast tissue biopsy to make an indentation, then visualized and measured the indentation with an indentation-type atomic force microscope, which provides unprecedented spatial resolution. "The most significant outcome of our measurements is determining that in healthy tissue the stiffness of the sample is homogeneous," Plodinec says. "Benign tissue exhibits a larger variability and malignant tissue shows a unique, very heterogeneous profile with soft and stiff parts alternating."

A key aspect of their experiment is the adaptation of atomic force microscopy to rapidly collect and correlate nanoscale stiffness measurements across entire biopsy samples. They used a device called ARTIDIS ("Automated and Reliable Tissue Diagnostics"), invented by Plodinec and colleagues Marko Loparic and Roderick Lim. Partnering with industry, their next step is to develop ARTIDIS into an easy-to-use device for clinical application, hopefully within two years.

"A critical advantage of ARTIDIS technology, as we see it, is that it provides an estimate of tumor aggressiveness and metastatic spread based on the unique nanomechanical signature," Plodinec says. "This signature may have potential prognostic and predictive value as a marker for therapeutic applications."


'/>"/>

Contact: Ellen R. Weiss
eweiss@biophysics.org
240-290-5606
American Institute of Physics
Source:Eurekalert

Related medicine news :

1. Moffitt Cancer Center researchers validate molecular signature to predict radiation therapy benefit
2. URMC researchers connect new genetic signature to leukemia
3. Moffitt researchers identify unique immune gene signature across thousands of patients solid tumors
4. ABC Home & Commercial Services’ Houston Branch Now Offering Discount on Initial Service with Signature Rodent Agreement
5. Personal epigenetic signatures found consistent in prostate cancer patients metastases
6. The Tampa Signature Massage Center Announces Couples Massage Awareness Month
7. Eliminating the good cholesterol receptor may fight breast cancer
8. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
9. Researchers develop a new cell and animal model of inflammatory breast cancer
10. Scientists uncover multiple faces of deadly breast cancer
11. Depo-Provera Birth Control Might Raise Breast Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... Physicians Education ... Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma, on ... “We are honored to have Amy E. Herman present at this year’s conference, ...
(Date:12/5/2016)... ... ... BSI and Brenntag Canada have been appointed by Chr. Hansen as their ... fruits and beverage colorants effective November 1, 2016. , “The ... product portfolio,” said Steve Brauer, President of Brenntag Specialties, Inc. “Representing Chr. Hansen will ...
(Date:12/5/2016)... ... December 05, 2016 , ... Sideline Products is a Southern York ... both the smaller rider and the horse. Smaller saddles can pinch and irritate the ... to fit over a properly fitted western saddle so it does not impact the ...
(Date:12/5/2016)... ... December 05, 2016 , ... “Life Will Never Be ... supportive family and friends. “Life Will Never Be The Same” is the creation of ... in writing children's books and holds a degree in Christian religion and philosophy from ...
(Date:12/5/2016)... ... ... MBA has joined the Retina Group of New York (RGONY) specializing in uveitis ... MD and has been providing tertiary medical and surgical retinal care on Long Island for ... her peers. Growing up in a family of doctors, Dr. Shah emulated the role ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... 2016  New research by the CVS Health ... the U.S. Department of Health and Human Services, ... Response (ASPR), published online today in JAMA ... encourage patients with chronic conditions to refill medications ... also affirms that public-private partnerships can facilitate timely ...
(Date:12/5/2016)... of Spectrum Science Communications , announced today that Jonathan ... consecutive years of high double digit growth in fee revenues. ... management of the firm that Seng founded in 1996. Earlier in ... the Year and was selected among the Best Places to Work. ... ...
(Date:12/5/2016)...  Seno Medical Instruments, Inc., the company pioneering the ... improve the process of diagnosing breast cancer, today announced ... post-market surveillance and clinical follow-up study at the 2016 ... place from December 6-10, 2016 at the Henry B. ... . Seno Medical Instruments will present ...
Breaking Medicine Technology: